Karuna Therapeutics logo
Karuna Therapeutics KRTX
$ 329.83 0.0%

Annual report 2023
added 02-22-2024

report update icon

Karuna Therapeutics Income Statement 2011-2024 | KRTX

Annual Income Statement Karuna Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

11.8 B 6.07 B 3.06 B 3.3 B 1.13 B - - - - - - - -

Shares

37 M 31.6 M 29.1 M 26.4 M 12 M - - - - - - - -

Historical Prices

319 192 105 125 87.3 - - - - - - - -

Net Income

-434 M -276 M -144 M -68.6 M -44 M -17.5 M -6.03 M - - - - - -

Revenue

654 K 10.6 M 37 M - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-495 M -290 M -144 M -71.8 M -45.4 M -14.5 M - - - - - - -

Interest Expense

- - - - - - - - - - - - -

EBITDA

-493 M -289 M -143 M -71.7 M -45.3 M -14.5 M -4.8 M - - - - - -

Operating Expenses

495 M 300 M 181 M 71.8 M 45.4 M - - - - - - - -

General and Administrative Expenses

131 M 76.1 M 52.6 M 28.4 M 20.9 M 2.97 M 1.19 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Karuna Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

37.7 M 37.5 M 34.8 M 34.5 M 32.3 M 29.9 M 29.8 M 29.8 M 29.6 M 29.5 M 27.8 M 27 M 26.7 M 26.2 M 26 M 26 M 22.9 M 104 K 2.68 K 12 5 12 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-119 M -103 M -97.6 M - -77 M -64.9 M -58.2 M - -50.9 M -34.4 M -30.5 M - -18.8 M -17 M -8.66 M - -9.04 M -15.1 M -12 M - -6.24 M -539 K -2.41 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - 654 K - 81 K 5.28 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-136 M -120 M -109 M - -81 M -65.1 M -58.6 M - -51.2 M -34.5 M -30 M - -19.5 M -17.8 M -10.1 M - -9.9 M -15.1 M -11.6 M - -2.47 M -2.43 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -109 M - -80.2 M -64.5 M -58.3 M - -50.9 M -34.4 M -29.9 M - -19.4 M -17.8 M -10 M - -9.86 M -15 M -11.6 M - -2.47 M -2.43 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

136 M 120 M 110 M - 81.1 M 70.3 M 58.6 M - 51.2 M 34.5 M 30 M - 19.5 M 17.8 M 10.1 M - 9.9 M 15.1 M 11.6 M - 2.47 M 2.43 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

32.3 M 27.4 M 24.3 M - 19.1 M 17.8 M 14.8 M - 12.4 M 10.4 M 9.78 M - 6.94 M 7.01 M 5.64 M - 4.1 M 8.29 M 4.61 M - 1.06 M 256 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency